Latest Updates & News

New Blood Test for Colon Cancer Recommended for Approval: May 24, 2024

New Blood Test for Colon Cancer Recommended for Approval: May 24, 2024

What is it prescribed for?   The Guardant Health Shield test is a blood test that screens for colorectal cancer (CRC) in people who are 45 and older and at average risk of the disease.  The test looks for DNA fragments from tumor cells and precancerous growths in blood samples collected with a Guardant Blood Collection Kit. What is the name of the drug and what...

New Liquid Medication Approved for ADHD Treatment: May 30, 2024

New Liquid Medication Approved for ADHD Treatment: May 30, 2024

What is Onyda XR prescribed for?   ONYDA XR (Clonidine Hydrochloride) is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy (using a single drug for a disease) and as adjunctive therapy (an additional treatment used alongside primary therapy to enhance effectiveness) to central nervous system (CNS) stimulant...

FDA Approves First CRISPR Gene Therapy in January 2024 to Treat Beta-Thalassemia

FDA Approves First CRISPR Gene Therapy in January 2024 to Treat Beta-Thalassemia

What is Casgevy prescribed for?   Casgevy is prescribed to treat people aged 12 years and older with sickle cell disease (SCD) who have frequent vaso-occlusive crises or VOCs. What is the name of the drug and what does it do?  Casgevy pronounced cass-JEH-vee, generic name:(exagamglogene autotemcel) is an innovative treatment specifically designed for...

Zurzuvae approved for treatment of postpartum depression on August 04, 2023

Zurzuvae approved for treatment of postpartum depression on August 04, 2023

What is Zurzuvae prescribed for? Zurzuvae is prescribed to treat postpartum depression in adults.  What is the name of the drug and what does it do? Zurzuvae, pronounced ZUR-zoo-vay, (generic name: zuranolone) is a medication approved for treating postpartum depression (PPD) in adults.  It belongs to a class of drugs known as neuroactive steroids, which...

Voquezna approved for Erosive Esophagitis and GERD by FDA on November, 2023

Voquezna approved for Erosive Esophagitis and GERD by FDA on November, 2023

What is Voquezna prescribed for? Voquenza is indicated for the treatment of Helicobacter pylori (H. pylori) infection in adults. What is the name of the drug and what does it do? Voquezna, pronounced voh-kez-nah, (generic name:vonoprazan) recently approved by the FDA, is a medication designed to treat erosive esophagitis and gastroesophageal reflux disease...